| In millions, except per share items | Jan-31-23 | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 |
| | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | -30.5% | -74.4% | -29.2% | 210.8% | |
| Cost of goods sold | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | 795.3% | -45.9% | 81.8% | 100.0% |
| Selling, general and administrative [+] | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| General and administrative | 0.0 | 0.1 | 0.0 | | 0.0 |
| Other operating expenses | | 0.1 | 0.0 | 0.1 | |
| EBITDA [+] | 0.0 | 0.0 | 0.0 | | 0.0 |
| EBITDA growth | -59.0% | 658.7% | 102.7% | -448.3% | |
| EBITDA margin | -250.8% | -425.1% | -14.4% | -5.0% | 4.5% |
| Depreciation and amortization | 0.0 | 0.0 | 0.0 | | 0.0 |
| EBIT [+] | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT growth | -64.6% | 136.2% | 810.7% | -46.7% | |
| EBIT margin | -303.0% | -594.6% | -64.5% | -5.0% | -29.2% |
| Other income (expense), net [+] | 0.0 | | | 0.0 | |
| Gain (loss) on sale of assets | 0.0 | | | | |
| Gain (loss) on investments | 0.0 | | | | |
| Other | 0.0 | | | | |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Earnings from continuing ops | 0.0 | 0.0 | 0.0 | | 0.0 |
| Earnings from discontinued ops | | | | 0.0 | |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | -825.3% | -594.6% | -64.5% | -5.4% | -29.2% |
| |
| Basic EPS [+] | $0.00 | ($0.01) | ($0.01) | $0.00 | $0.00 |
| Growth | -81.0% | 93.2% | | -100.0% | |
| Diluted EPS [+] | $0.00 | ($0.01) | ($0.01) | $0.00 | $0.00 |
| Growth | -81.0% | 93.2% | | -100.0% | |
| |
| |
| Shares outstanding (basic) [+] | 19.0 | 3.7 | 3.1 | 2.8 | 2.8 |
| Growth | 408.9% | 22.3% | 7.5% | 1.4% | |
| Shares outstanding (diluted) [+] | 19.0 | 3.7 | 3.1 | 2.8 | 2.8 |
| Growth | 408.9% | 22.3% | 7.5% | 1.4% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |